Metabolite profiles in heart failure: looking for unique signatures in a heterogeneous syndrome.

[1]  H. Ho,et al.  Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. , 2015, Journal of the American College of Cardiology.

[2]  S. Anker,et al.  Metabolic impairment in heart failure: the myocardial and systemic perspective. , 2014, Journal of the American College of Cardiology.

[3]  S. Solomon,et al.  Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities). , 2013, JACC. Heart failure.

[4]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[5]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[6]  L. Tenori,et al.  Metabolomic fingerprint of heart failure in humans: a nuclear magnetic resonance spectroscopy analysis. , 2013, International journal of cardiology.

[7]  Junpeng Zhang,et al.  Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure. , 2013, Molecular bioSystems.

[8]  E. Boerwinkle,et al.  Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study. , 2013, American journal of epidemiology.

[9]  W. Paulus,et al.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.

[10]  A. Turkieh,et al.  Metabonomics Analysis of Plasma Reveals the Lactate to Cholesterol Ratio as an Independent Prognostic Factor of Short-Term Mortality in Acute Heart Failure , 2013, PloS one.

[11]  Raed A Dweik,et al.  Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure. , 2013, Journal of the American College of Cardiology.

[12]  William E. Kraus,et al.  Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases: Form and Function , 2012, Circulation.

[13]  G. Fonarow,et al.  Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. , 2010, Journal of the American College of Cardiology.

[14]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association , 2009, Circulation.

[15]  D. Glower,et al.  Metabolomic Profiling Reveals Distinct Patterns of Myocardial Substrate Use in Humans With Coronary Artery Disease or Left Ventricular Dysfunction During Surgical Ischemia/Reperfusion , 2009, Circulation.

[16]  Thomas J. Wang,et al.  The search for new cardiovascular biomarkers , 2008, Nature.

[17]  David I. Ellis,et al.  Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate , 2007, Metabolomics.

[18]  D. Muthu,et al.  Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure , 2009 .